1. Home
  2. NRIM vs SCTX Comparison

NRIM vs SCTX Comparison

Compare NRIM & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NRIM

Northrim BanCorp Inc

HOLD

Current Price

$25.16

Market Cap

602.6M

Sector

Finance

ML Signal

HOLD

Logo Scribe Therapeutics Inc. Common Stock

SCTX

Scribe Therapeutics Inc. Common Stock

N/A

Current Price

$28.18

Market Cap

536.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NRIM
SCTX
Founded
1990
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
602.6M
536.5M
IPO Year
2002
2026

Fundamental Metrics

Financial Performance
Metric
NRIM
SCTX
Price
$25.16
$28.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
103.6K
220.5K
Earning Date
04-22-2026
N/A
Dividend Yield
2.62%
N/A
EPS Growth
N/A
N/A
EPS
1.29
N/A
Revenue
$255,581,000.00
N/A
Revenue This Year
$4.98
N/A
Revenue Next Year
$7.40
N/A
P/E Ratio
$19.55
N/A
Revenue Growth
30.43
N/A
52 Week Low
$19.60
$17.31
52 Week High
$30.82
$39.60

Technical Indicators

Market Signals
Indicator
NRIM
SCTX
Relative Strength Index (RSI) 32.78 49.37
Support Level $24.87 $27.41
Resistance Level $25.45 $39.60
Average True Range (ATR) 0.56 3.41
MACD -0.07 -0.40
Stochastic Oscillator 3.87 34.66

Price Performance

Historical Comparison
NRIM
SCTX

About NRIM Northrim BanCorp Inc

Northrim BanCorp Inc is a bank holding company operating through three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. The Community Banking segment, which generates the majority of revenue, provides loan and deposit products to business and consumer customers in its market areas. The Home Mortgage Lending segment focuses on the origination and sale of mortgage loans for one-to-four family residential properties, mortgage loan servicing for certain loans sold, and investment in selected residential mortgage loans. The Specialty Finance segment provides factoring, asset-based lending, and alternative working capital solutions to small and medium-sized enterprises and includes SCF and Northrim Funding Services.

About SCTX Scribe Therapeutics Inc. Common Stock

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Share on Social Networks: